)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Vivesto
Vivesto (VIVE) investor relations material
Vivesto Study result summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Study result summary19 Oct, 2026
Top-line findings
In dogs, Paccal Vet doubled overall survival versus surgery alone.
Preliminary results from all 21 enrolled cats showed anti-tumor effects across multiple tumor types and dose levels.
Best biological responses were observed in 15 cats: 1 complete response, 6 partial responses and 8 cases of stable disease for at least six weeks.
Dog and cat study results supported safety and tolerability, with no hypersensitivity reactions observed.
Current dog-study findings build on prior exposure of more than 300 dogs to the compound.
Safety and tolerability
In cats, side effects included decreased appetite, lethargy and neutropenia; they were mostly mild, temporary and manageable with supportive medication.
Clinical potential
For splenic hemangiosarcoma, Paccal Vet could serve dogs unable to safely receive doxorubicin or as an option after doxorubicin failure.
Anti-cancer responses across feline tumor types, some within days, address limited standard options and unmet need in feline oncology.
The first feline trial achieved doses higher than in a previous study of conventional human paclitaxel, informing future dose selection.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Vivesto
- Clinical programs advance as planned; strong cash position supports operations into 2027.VIVE
Q2 2026 - Strengthened finances and clinical progress position for key data and partnerships in 2026.VIVEQ1 2026
- Positive clinical progress and strengthened financial position with new capital raised.VIVEQ4 2025
- Pakalvet doubles survival in canine cancer; Cantrixil shows strong preclinical efficacy.VIVEDNB Carnegie Småbolagsdag
- Positive clinical progress and improved financials, but future funding is critical.VIVEQ3 2025
- Strong interim results and funding support advance key oncology programs toward 2026 milestones.VIVEStudy update
- Clinical and financial progress continues, with interim data and new partnerships on the horizon.VIVEQ2 2025
- Losses narrowed as Vivesto advanced cancer programs and secured a key licensing deal.VIVEQ3 2024
- Cost reductions and strategic deals improved Vivesto's financials and advanced oncology pipeline.VIVEQ4 2024
Next Vivesto earnings date
Q3 202612 Nov, 2026
Vivesto
Next Vivesto earnings date
Q3 202612 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage